AR074297A1 - Combinacion farmaceutica sinergica que comprende un atagonista del receptor de estrogeno y una progestina - Google Patents
Combinacion farmaceutica sinergica que comprende un atagonista del receptor de estrogeno y una progestinaInfo
- Publication number
- AR074297A1 AR074297A1 ARP090104296A ARP090104296A AR074297A1 AR 074297 A1 AR074297 A1 AR 074297A1 AR P090104296 A ARP090104296 A AR P090104296A AR P090104296 A ARP090104296 A AR P090104296A AR 074297 A1 AR074297 A1 AR 074297A1
- Authority
- AR
- Argentina
- Prior art keywords
- acetate
- org
- beta
- pharmaceutical combination
- 7alpha
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102008057230A DE102008057230A1 (de) | 2008-11-11 | 2008-11-11 | Synergistische pharmazeutische Kombination mit einem Estrogenrezeptorantagonisten und einem Progestin |
Publications (1)
Publication Number | Publication Date |
---|---|
AR074297A1 true AR074297A1 (es) | 2011-01-05 |
Family
ID=41606625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP090104296A AR074297A1 (es) | 2008-11-11 | 2009-11-06 | Combinacion farmaceutica sinergica que comprende un atagonista del receptor de estrogeno y una progestina |
Country Status (6)
Country | Link |
---|---|
AR (1) | AR074297A1 (de) |
DE (1) | DE102008057230A1 (de) |
PA (1) | PA8847901A1 (de) |
TW (1) | TW201022251A (de) |
UY (1) | UY32235A (de) |
WO (1) | WO2010054758A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102481294A (zh) * | 2009-09-11 | 2012-05-30 | 拜耳医药股份有限公司 | 作为抗癌药物的取代(杂芳基甲基)乙内酰硫脲 |
WO2013131105A1 (en) * | 2012-03-02 | 2013-09-06 | Sri International | Synergistic anti-proliferation activity of tas-108 with mtor inhibitors against cancer cells |
WO2016004166A1 (en) * | 2014-07-02 | 2016-01-07 | Xavier University Of Louisiana | Boron-based prodrug strategy for increased bioavailability and lower-dosage requirements for drug molecules containing at least one phenol (or aromatic hydroxyl) group |
CN104370796B (zh) * | 2014-11-21 | 2016-09-14 | 扬子江药业集团有限公司 | 一种醋酸巴多昔芬多晶型b的制备方法 |
KR20180059427A (ko) | 2015-07-14 | 2018-06-04 | 노벨파마 컴퍼니 리미티드 | 에스트로겐 수용체 α 저해 작용을 갖는 에스트로겐 수용체 β 부분 아고니스트 및 이를 사용한 부인과 질환 치료제 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19635525A1 (de) | 1996-08-20 | 1998-02-26 | Schering Ag | 7alpha-(xi-Aminoalkyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha(xi-Aminoalkyl-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln |
UA68365C2 (en) * | 1997-11-06 | 2004-08-16 | Wyeth Corp | Peroral contraception by combination of anti-estrogen and progestin |
US6265393B1 (en) | 1998-08-07 | 2001-07-24 | Heinrichs William Leroy | Prevention of endometriosis signs or symptons |
DE60005693T2 (de) * | 1999-07-29 | 2004-07-29 | Eli Lilly And Co., Indianapolis | Eine kristalline form von 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophen-hydrochlorid |
DE10013782A1 (de) | 2000-03-15 | 2001-10-18 | Schering Ag | 4-Fluoralkyl-2H-benzopyrane mit antiestrogener Wirksamkeit, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, die diese enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln |
DE10159217A1 (de) | 2001-11-27 | 2003-06-05 | Schering Ag | 17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate |
WO2003063859A1 (en) * | 2002-01-14 | 2003-08-07 | Nordic Bioscience A/S | Suppression of cartilage degradation via the estrogen receptor |
TW200307553A (en) * | 2002-05-24 | 2003-12-16 | Akzo Nobel Nv | Treatment of post-menopausal complaints in breast cancer patients |
JP4656939B2 (ja) | 2002-07-22 | 2011-03-23 | イーライ リリー アンド カンパニー | フェニルスルホニル基を含む選択的エストロゲン受容体モジュレーター |
US20080021003A1 (en) * | 2006-06-13 | 2008-01-24 | Vladimir Hanes | Extended step-down estrogen regimen |
-
2008
- 2008-11-11 DE DE102008057230A patent/DE102008057230A1/de not_active Withdrawn
-
2009
- 2009-10-31 WO PCT/EP2009/007801 patent/WO2010054758A1/en active Application Filing
- 2009-11-06 AR ARP090104296A patent/AR074297A1/es unknown
- 2009-11-09 PA PA20098847901A patent/PA8847901A1/es unknown
- 2009-11-10 UY UY0001032235A patent/UY32235A/es not_active Application Discontinuation
- 2009-11-11 TW TW098138262A patent/TW201022251A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
TW201022251A (en) | 2010-06-16 |
UY32235A (es) | 2010-06-30 |
WO2010054758A1 (en) | 2010-05-20 |
PA8847901A1 (es) | 2010-06-28 |
DE102008057230A1 (de) | 2010-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR074297A1 (es) | Combinacion farmaceutica sinergica que comprende un atagonista del receptor de estrogeno y una progestina | |
AR057060A1 (es) | Composiciones de tanaproget que contienen etinil estradiol | |
BR112012014059A2 (pt) | gel transdérmico de progestina / estradiol. | |
MX347890B (es) | Neuroproteccion y reparacion de melina usando progestina. | |
DOP2012000015A (es) | (11ß,17ß)17HIDROXI11[4(METILSULFONIL)FENIL]17(PENTAFLUOROETIL)ESTRA4,9DIEN3ONA CON ACCIÓN ANTAGONISTA EN EL RECEPTOR DE PROGESTERONA | |
PE20211588A1 (es) | Compuestos y sus usos para aliviar sintomas asociados a la menopausia | |
RU2011149223A (ru) | Внутриматочная система для лечебного использования | |
CA2369077A1 (en) | Contraceptive compositions containing quinazolinone and benzoxazine derivatives | |
RS89504A (en) | 5-(2-hidroxy-3-/1-(3-trifluoromethylphenyl)-cyclopropyl/-propionylamino)-phtalide and related compounds with progesterone receptor modulating activity for use ine fertility control and hormone replacement therapy | |
PE20130524A1 (es) | Forma farmaceutica parenteral, que libera inhibidores de aromatasa y gestagenos para el tratamiento de endometrosis | |
HN2008000621A (es) | Metodo para la anticopcepcion hormonal preventiva bajo demanda | |
NZ597583A (en) | Treatment of alzheimer’s disease, loss of cognition, memory loss and dementia with sex steroid precursors in combination with selective estrogen receptor modulators | |
JP2011518883A5 (de) | ||
JP2014532685A (ja) | 18−メチル−6,7−メチレン−3−オキソ−17−プレグナ−4−エン−21,17β−カルボラクトン、該化合物を含有する医薬製剤、および子宮内膜症の治療におけるその使用 | |
MY161549A (en) | Progesterone antagonists such as cdb-4124 in the treatment of breast cancer | |
WO2009138186A3 (de) | SEQUENTIELLE VERARBEITUNG VON 20,20,21,21-PENTAFLUOR-17-HYDROXY-11β-[4-(HYDROXYACETYL) PHENYL] -19-NOR-17α-PREGNA-4,9-DIEN-3-ON UND EINEM ODER MEHREREN GESTAGENEN ZUR BEHANDLUNG GYNÄKOLOGISCHER ERKRANKUNGEN | |
AR121864A1 (es) | Composiciones anticonceptivas con efectos adversos reducidos | |
CZ299942B6 (cs) | Farmaceutické prostredky obsahující antiprogestinpro prevenci a lécení hormonálne závislých onemocnení | |
PE20070182A1 (es) | Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona | |
TN2015000454A1 (en) | Progesterone receptor antagonist dosage form | |
UY28334A1 (es) | Composicion que comprende antagonistas de receptores de progesterona y antiestrógenos puros para la profilaxis y el tratamiento de enfermedades dependientes de hormonas. | |
MA32477B1 (fr) | Derives estratrienes comprenant des bioisosteres heterocycliques pour le cycle a phenolique | |
Wilkens et al. | Progesterone receptor modulators in gynaecological practice | |
BRPI0511864A (pt) | uso de uma combinação de etinilestradiol e acetato de clormadinona para a preparação de um medicamento | |
ATE419855T1 (de) | Therapie für hormonersatz und depression enthaltend dienogest |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |